Introduction
Fetal anaemia can be secondary to both immune and non-immune conditions. Maternal sensitization happens when a pregnant woman is carrying a fetus with paternally derived red-cell antigen that is foreign to the mother. Since primary immune response takes time to activate, first pregnancy usually does not affect. In subsequent pregnancies antibody response is rapid and antibodies are formed in greater concentration. These antibodies may cross the placenta, bind to antigens present on the fetal erythrocytes, and cause hemolysis, hydrops fetalis, and fetal death.
Rhesus (Rh) alloimmunization is the most common cause for severe haemolytic disease of the fetus. Incidence of fetal anaemia due to Rh incompatibility has been declining over the past decades with the introduction of anti-D prophylaxis in 1969. Despite routine use of anti-D prophylaxis, it has been estimated that nearly 600-700 new cases of rhesus sensitization still occur each year in the UK 1 . This is primarily due to silent fetomaternal heamorrhage and inadequate dose of anti-D prophylaxis.
Haemolytic disease of the fetus due to other redcell antibodies such as anti-c, K1 (Kell), Duffy and anti-E have gained importance as Rhesus D alloimmunization has become less of a problem. Non-immune conditions such as massive fetomaternal hemorrhage and fetal infection following human parvovirus B19 (HPVB19) are other important causes of fetal anaemia.
Prediction of fetal anaemia
Primary objective of monitoring at risk fetus of severe haemolytic disease is to timely diagnosis of anaemia which needs fetal blood transfusion and delivers them at appropriate time. Rh sensitized mothers need regular Rh antibody level assessment and antibody level >4 IU (~1:32) is considered significant. Antibody level >10 IU (~1:64) puts fetus at risk of haemolytic disease and >15 IU (~1:132) confers very high risk of fetal anaemia. Fetus is at greater risk of anaemia if the antibody levels are >10 IU (~1:64) at the beginning of the pregnancy or rise suddenly. Rising antibody titre warrants urgent referral to a fetal medicine unit for further management.
Invasive methods such as amniocentesis and fetal blood sampling (FBS) were the choices in past to screen the high risk fetuses for severe haemolytic disease. Amniocentesis indirectly identifies level of fetal anaemia by quantifying bilirubin (delta optical density 450, OD450) present in the amniotic fluid as a result of fetal hemolysis. It does not provide information about the hemopoietic response of the fetus and serial procedures are usually required to monitor the pregnancy. This method shows a lack of accuracy before 27 weeks of gestation and in predicting the severity of anaemia 2,3 . Moreover, in pregnancies affected by Kell alloimmunization or HPVB19 infection, the correlation between the delta optical density 450 (OD450) and anaemia is poor as the anaemia is caused by decreased hematopoiesis rather than red blood cell destruction 4, 5 . Cordocentesis and FBS can identify fetal anaemia reliably but this procedure is known to associate with complications such as, bleeding from the cord puncture site, transient bradycardia, worsening of fetal alloimmunization and fetal demise 6 .
It has been clearly reveled that cerebral arteries respond quickly to hypoxemia due to the strong dependence of brain tissue on oxygen. Peak systolic velocity of the middle cerebral artery (MCA-PSV), as measured by Doppler ultrasonography, is increased in fetuses with anaemia 7 . The advantage of studying the MCA is easy visualization with an angle of close to 0 degrees between the ultrasound beam and the direction of blood flow and this measurement has low intra-observer and inter-observer variability 7 . The measurement of the MCA-PSV can predict the presence of moderate or severe anaemia in fetuses with a sensitivity of 100% and a false positive rate of 12% of a PSV threshold of 1.5 MoM 8 ( Figure 1 ).
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Technique
An axial section of the brain, including the thalami and the cavum septi pellucidi, should be obtained. Then the circle of Willis should be visualized and the middle cerebral artery of one side needs to be examined close to its origin in the internal carotid artery as the systolic velocity decreases with distance from the point of origin of this vessel. The angle between the ultrasound beam and the direction of blood flow should be kept as close as possible to 0 degrees. The highest point of the wave form (peak systolic velocity) needs to be measured (Figure 2) . 
Intrauterine transfusion (IUT)
In the absence of systematic referral system and prompt IUT facilities, severe Rh alloimmunization confers high perinatal morbidity and mortality. IUT was not routinely performed in Sri Lanka and it has been recently started 9 . The first intrauterine fetal blood transfusion was performed in 1963 by Liley, utilizing an intraperitoneal approach 10 .With time the procedure has been modified to involve an intravascular approach the safety of which has increased with improvements in ultrasound technology 11 . Recognized intravascular techniques utilize for intrauterine blood transfusions include cordocentesis (usually into the umbilical vein either at the point where the cord inserts into the placenta or into the baby's liver, or into a free loop of cord) or into a blood vessel in the baby's liver (intrahepatic transfusion) (Figure 3) . Intrauterine blood transfusion is associated with complications such as preterm prelabour rupture of membranes, chorioamnionitis, preterm labour, and fetal distress. These complication may necessitate emergency delivery and result in preterm birth and its' complications. Often a baby will require repeated transfusions during the course of a pregnancy and these repeated procedures will promote additional antibody formation. Increasing antibody sensitization further exacerbates the fetal haemolytic process. Moreover, Inutero transfusion of blood suppresses the baby's erythropoiesis and this suppression requires repeat transfusions during the course of the pregnancy, and the need for top-up transfusions after the baby's birth.
